vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and VAALCO ENERGY INC (EGY). Click either name above to swap in a different company.
VAALCO ENERGY INC is the larger business by last-quarter revenue ($91.0M vs $62.1M, roughly 1.5× Cytek Biosciences, Inc.). VAALCO ENERGY INC runs the higher net margin — -64.4% vs -70.9%, a 6.6% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -25.2%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -4.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
VAALCO Energy is a company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Houston, Texas with operations primarily in the Etame Marin block offshore Gabon.
CTKB vs EGY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $91.0M |
| Net Profit | $-44.1M | $-58.6M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | -71.3% |
| Net Margin | -70.9% | -64.4% |
| Revenue YoY | 8.1% | -25.2% |
| Net Profit YoY | -557.1% | -602.5% |
| EPS (diluted) | — | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $91.0M | ||
| Q3 25 | $52.3M | $61.0M | ||
| Q2 25 | $45.6M | $96.9M | ||
| Q1 25 | $41.5M | $110.3M | ||
| Q4 24 | $57.5M | $121.7M | ||
| Q3 24 | $51.5M | $140.3M | ||
| Q2 24 | $46.6M | $116.8M | ||
| Q1 24 | $44.9M | $100.2M |
| Q4 25 | $-44.1M | $-58.6M | ||
| Q3 25 | $-5.5M | $1.1M | ||
| Q2 25 | $-5.6M | $8.4M | ||
| Q1 25 | $-11.4M | $7.7M | ||
| Q4 24 | $9.6M | $11.7M | ||
| Q3 24 | $941.0K | $11.0M | ||
| Q2 24 | $-10.4M | $28.2M | ||
| Q1 24 | $-6.2M | $7.7M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | -71.3% | ||
| Q3 25 | -17.6% | 1.5% | ||
| Q2 25 | -23.3% | 17.7% | ||
| Q1 25 | -36.1% | 23.7% | ||
| Q4 24 | 5.2% | 32.7% | ||
| Q3 24 | -8.2% | 31.4% | ||
| Q2 24 | -18.3% | 17.5% | ||
| Q1 24 | -23.9% | 32.1% |
| Q4 25 | -70.9% | -64.4% | ||
| Q3 25 | -10.5% | 1.8% | ||
| Q2 25 | -12.2% | 8.6% | ||
| Q1 25 | -27.5% | 7.0% | ||
| Q4 24 | 16.8% | 9.6% | ||
| Q3 24 | 1.8% | 7.8% | ||
| Q2 24 | -22.4% | 24.1% | ||
| Q1 24 | -13.8% | 7.7% |
| Q4 25 | — | $-0.56 | ||
| Q3 25 | — | $0.01 | ||
| Q2 25 | — | $0.08 | ||
| Q1 25 | — | $0.07 | ||
| Q4 24 | — | $0.12 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $0.27 | ||
| Q1 24 | — | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $58.9M |
| Total DebtLower is stronger | — | $60.0M |
| Stockholders' EquityBook value | $341.7M | $443.5M |
| Total Assets | $461.5M | $913.4M |
| Debt / EquityLower = less leverage | — | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $58.9M | ||
| Q3 25 | $93.3M | $24.0M | ||
| Q2 25 | $75.5M | $67.9M | ||
| Q1 25 | $95.3M | $40.9M | ||
| Q4 24 | $98.7M | $82.7M | ||
| Q3 24 | $162.3M | $89.1M | ||
| Q2 24 | $177.9M | $62.9M | ||
| Q1 24 | $168.8M | $113.3M |
| Q4 25 | — | $60.0M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
| Q4 25 | $341.7M | $443.5M | ||
| Q3 25 | $378.6M | $505.9M | ||
| Q2 25 | $377.6M | $511.6M | ||
| Q1 25 | $379.6M | $504.1M | ||
| Q4 24 | $395.7M | $501.6M | ||
| Q3 24 | $385.5M | $501.0M | ||
| Q2 24 | $389.1M | $493.6M | ||
| Q1 24 | $392.6M | $472.6M |
| Q4 25 | $461.5M | $913.4M | ||
| Q3 25 | $494.9M | $950.4M | ||
| Q2 25 | $493.3M | $964.9M | ||
| Q1 25 | $482.6M | $927.1M | ||
| Q4 24 | $499.5M | $955.0M | ||
| Q3 24 | $491.2M | $937.9M | ||
| Q2 24 | $483.7M | $917.4M | ||
| Q1 24 | $492.1M | $809.1M |
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $145.2M |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $145.2M | ||
| Q3 25 | $-3.9M | $16.4M | ||
| Q2 25 | $108.0K | $18.3M | ||
| Q1 25 | $-125.0K | $32.7M | ||
| Q4 24 | $2.0M | $44.5M | ||
| Q3 24 | $13.2M | $47.8M | ||
| Q2 24 | $6.2M | $-438.0K | ||
| Q1 24 | $4.0M | $21.8M |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | $29.7M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | 26.9% | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | 2.7% | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 14.94× | ||
| Q2 25 | — | 2.19× | ||
| Q1 25 | — | 4.23× | ||
| Q4 24 | 0.21× | 3.82× | ||
| Q3 24 | 14.05× | 4.35× | ||
| Q2 24 | — | -0.02× | ||
| Q1 24 | — | 2.84× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
EGY
| Crude Oil Sales And Purchase Agreements | $54.8M | 60% |
| Other | $31.9M | 35% |
| Crude Oil | $3.0M | 3% |
| Natural Gas Liquids Reserves | $1.4M | 2% |
